quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:30:00·820d
PRRelease
NightHawk Biosciences Inc. logo

NightHawk's Scorpius BioManufacturing Subsidiary Awarded Multimillion- Dollar Contract with a Publicly Traded Biotech Company to Support its Phase 2 Clinical Program

NHWK· NightHawk Biosciences Inc.
Health Care
Original source

Companies

  • NHWK
    NightHawk Biosciences Inc.
    Health Care

Related

  • PR766d
    Scorpius Holdings Awarded Contract in Excess of $1 Million with NIH-Funded Researcher at a Major University
  • PR771d
    Scorpius Holdings Accepted as a Member of the US Government's BioMaP-Consortium
  • PR772d
    Scorpius Holdings, Inc. Announces Closing of Public Offering
  • PR777d
    Scorpius Holdings, Inc. Announces Pricing of Public Offering
  • PR777d
    Scorpius Holdings, Inc. Announces Proposed Public Offering of Common Stock
  • PR778d
    Scorpius Holdings Estimates Greater than 375% Sequential Increase in Revenue for the Fourth Quarter of 2023 Compared to the Third Quarter of 2023
  • SEC808d
    NightHawk Biosciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
  • NEWS808d
    NightHawk Biosciences Completes Name Change To Scorpius Holdings; Trading To Commence Under "SCPX" Effective At The Market Open Today
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022